F.D.A. Firings Decimated Teams Reviewing A.I. and Food Safety
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Interesting Engineering on MSN3d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Medscape4d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Endocrinology Advisor2d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Capital Public Radio3d
State insulin program still has no firm timeline
“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...
Sierra Sun Times4d
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...
Pacific Daily News2d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...
Medical News Today1d
Artificial sweetener may increase heart disease risk by triggering insulin surges
A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...
MyNewsLA on MSN4d
Bloomberg Industry Group Sues Non-Profit Drug Manufacturer for Producing Insulin at Lower Costs
The Bloomberg Industry Group has filed a legal action against a state agency challenging the transparency of an agreement to ...
News Medical on MSN22h
The dangers of fraudulent diabetes products and how to avoid them
As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, ...
‘First of its kind’ medication can significantly reduce heart attacks and strokes
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...